{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:53:16Z","timestamp":1789962796113,"version":"4.0.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00702-014-1205-3","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T11:31:24Z","timestamp":1405942284000},"page":"1387-1397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)"],"prefix":"10.1007","volume":"121","author":[{"given":"Marta","family":"\u0141ukaszewicz-Zaj\u0105c","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mroczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"S\u0142owik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"1205_CR1","first-page":"60","volume":"20","author":"M Asahina","year":"2001","unstructured":"Asahina M, Yoshiyama Y, Hattori T (2001) Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer\u2019s disease brain. Clin Neuropathol 20:60\u201363","journal-title":"Clin Neuropathol"},{"key":"1205_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13167-010-0026-1","volume":"1","author":"C Benkler","year":"2010","unstructured":"Benkler C, Offen D, Melamed E, Kupershmidt L, Amit T, Mandel S et al (2010) Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application. EPMA J 1:343\u2013361","journal-title":"EPMA J"},{"key":"1205_CR3","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1097\/00001756-200011090-00003","volume":"11","author":"W Beuche","year":"2000","unstructured":"Beuche W, Yushchenko M, M\u00e4der M, Maliszewska M, Felgenhauer K, Weber F (2000) Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport 11:3419\u20133422","journal-title":"Neuroreport"},{"key":"1205_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1749-6632.1999.tb07675.x","volume":"878","author":"W Bode","year":"1999","unstructured":"Bode W, Fernandez-Catalan C, Grams F, Gomis-R\u00fcth FX, Nagase H, Tschesche H et al (1999) Insights into MMP-TIMP interactions. Ann N Y Acad Sci 878:73\u201391","journal-title":"Ann N Y Acad Sci"},{"key":"1205_CR5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00109-009-0584-7","volume":"88","author":"P Bossolasco","year":"2010","unstructured":"Bossolasco P, Cova L, Calzarossa C, Servida F, Mencacci NE, Onida F et al (2010) Metalloproteinase alterations in the bone marrow of ALS patients. J Mol Med (Berl) 88:553\u2013564","journal-title":"J Mol Med (Berl)"},{"key":"1205_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcancer.2010.05.002","volume":"20","author":"D Bourboulia","year":"2010","unstructured":"Bourboulia D, Stetler-Stevenson WG (2010) Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20:161\u2013168","journal-title":"Semin Cancer Biol"},{"key":"1205_CR7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/mus.21488","volume":"40","author":"R Bowser","year":"2009","unstructured":"Bowser R, Lacomis D (2009) Applying proteomics to the diagnosis and treatment of ALS and related diseases. Muscle Nerve 40:753\u2013762","journal-title":"Muscle Nerve"},{"key":"1205_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","volume":"1803","author":"K Brew","year":"2010","unstructured":"Brew K, Nagase H (2010) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803:55\u2013571","journal-title":"Biochim Biophys Acta"},{"key":"1205_CR9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuroscience.2008.06.025","volume":"158","author":"E Candelario-Jalil","year":"2009","unstructured":"Candelario-Jalil E, Yang Y, Rosenberg GA (2009) Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158:983\u2013994","journal-title":"Neuroscience"},{"key":"1205_CR10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/17482960802566824","volume":"10","author":"A Chi\u00f2","year":"2009","unstructured":"Chi\u00f2 A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E et al (2009) Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 10:310\u2013323","journal-title":"Amyotroph Lateral Scler"},{"key":"1205_CR11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","volume":"41","author":"A Chi\u00f2","year":"2013","unstructured":"Chi\u00f2 A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA et al (2013) Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41:118\u20131130","journal-title":"Neuroepidemiology"},{"key":"1205_CR12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/ars.2007.1760","volume":"10","author":"M Cozzolino","year":"2008","unstructured":"Cozzolino M, Ferri A, Carr\u00ec MT (2008) Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications. Antioxid Redox Signal 10:405\u2013443","journal-title":"Antioxid Redox Signal"},{"key":"1205_CR13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1212\/01.wnl.0000258551.96893.6f","volume":"68","author":"S Cronin","year":"2007","unstructured":"Cronin S, Hardiman O, Traynor BJ (2007) Ethnic variation in the incidence of ALS: a systematic review. Neurology 68:1002\u20131007","journal-title":"Neurology"},{"key":"1205_CR14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.0b013e3181d72c31","volume":"74","author":"ME Cudkowicz","year":"2010","unstructured":"Cudkowicz ME, Swash M (2010) CSF markers in amyotrophic lateral sclerosis: has the time come? Neurology 74:949\u2013950","journal-title":"Neurology"},{"key":"1205_CR15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jneuroim.2004.09.015","volume":"159","author":"M Demestre","year":"2005","unstructured":"Demestre M, Parkin-Smith G, Petzold A, Pullen AH (2005) The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis. J Neuroimmunol 159:146\u2013154","journal-title":"J Neuroimmunol"},{"key":"1205_CR16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13760-012-0067-4","volume":"112","author":"R Demir","year":"2012","unstructured":"Demir R, Ulvi H, Ozel L, Ozdemir G, G\u00fczelcik M, Ayg\u00fcl R (2012) Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke. Acta Neurol Belg 112:351\u2013356","journal-title":"Acta Neurol Belg"},{"key":"1205_CR17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00001756-200503150-00003","volume":"16","author":"M Dewil","year":"2005","unstructured":"Dewil M, Schurmans C, Starckx S, Opdenakker G, Van Den Bosch L, Robberecht W (2005) Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis. Neuroreport 16:321\u2013324","journal-title":"Neuroreport"},{"key":"1205_CR18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pmr.2012.08.022","volume":"24","author":"A Duleep","year":"2013","unstructured":"Duleep A, Shefner J (2013) Electrodiagnosis of motor neuron disease. Phys Med Rehabil Clin N Am 24:139\u2013151","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"1205_CR19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161\u2013174","journal-title":"Nat Rev Cancer"},{"key":"1205_CR20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jns.2009.05.025","volume":"285","author":"L Fang","year":"2009","unstructured":"Fang L, Huber-Abel F, Teuchert M, Hendrich C, Dorst J, Schattauer D et al (2009) Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). J Neurol Sci 285:62\u201366","journal-title":"J Neurol Sci"},{"key":"1205_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jns.2010.04.005","volume":"294","author":"L Fang","year":"2010","unstructured":"Fang L, Teuchert M, Huber-Abel F, Schattauer D, Hendrich C, Dorst J et al (2010) MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS. J Neurol Sci 294:51\u201356","journal-title":"J Neurol Sci"},{"key":"1205_CR22","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/sj.bjc.6990291","volume":"79","author":"PA Forsyth","year":"1999","unstructured":"Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H et al (1999) Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79:1828\u20131835","journal-title":"Br J Cancer"},{"key":"1205_CR23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2217\/bmm.09.71","volume":"4","author":"J Ganesalingam","year":"2010","unstructured":"Ganesalingam J, Bowser R (2010) The application of biomarkers in clinical trials for motor neuron disease. Biomark Med 4:281\u2013297","journal-title":"Biomark Med"},{"key":"1205_CR24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","volume":"117","author":"J Ganesalingam","year":"2011","unstructured":"Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, Bowser R (2011) Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J Neurochem 117:528\u2013537","journal-title":"J Neurochem"},{"key":"1205_CR25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/17482960802160990","volume":"9","author":"S Garbuzova-Davis","year":"2008","unstructured":"Garbuzova-Davis S, Saporta S, Sanberg PR (2008) Implications of blood-brain barrier disruption in ALS. Amyotroph Lateral Scler 9:375\u2013376","journal-title":"Amyotroph Lateral Scler"},{"key":"1205_CR26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2011.04.049","volume":"1398","author":"S Garbuzova-Davis","year":"2011","unstructured":"Garbuzova-Davis S, Rodrigues MC, Hernandez-Ontiveros DG, Louis MK, Willing AE, Borlongan CV et al (2011) Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res 1398:113\u2013125","journal-title":"Brain Res"},{"key":"1205_CR27","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2741\/1883","volume":"11","author":"Y Gasche","year":"2006","unstructured":"Gasche Y, Soccal PM, Kanemitsu M, Copin JC (2006) Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain. Front Biosci 11:1289\u20131301","journal-title":"Front Biosci"},{"key":"1205_CR28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.14336\/AD.2013.0400295","volume":"4","author":"PH Gordon","year":"2013","unstructured":"Gordon PH (2013) Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis 4:295\u2013310","journal-title":"Aging Dis"},{"key":"1205_CR29","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1126\/science.1073634","volume":"297","author":"Z Gu","year":"2002","unstructured":"Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A et al (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297:1186\u20131190","journal-title":"Science"},{"key":"1205_CR30","doi-asserted-by":"crossref","first-page":"e73777","DOI":"10.1371\/journal.pone.0073777","volume":"8","author":"X He","year":"2013","unstructured":"He X, Zhang L, Yao X, Hu J, Yu L, Jia H et al (2013) Association studies of MMP-9 in Parkinson\u2019s disease and amyotrophic lateral sclerosis. PLoS One 8:e73777","journal-title":"PLoS One"},{"key":"1205_CR31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2013.12.009","volume":"81","author":"A Kaplan","year":"2014","unstructured":"Kaplan A, Spiller KJ, Towne C, Kanning KC, Choe GT, Geber A, Akay T et al (2014) Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron 81:333\u2013348","journal-title":"Neuron"},{"key":"1205_CR32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2007.01.036","volume":"205","author":"M Kiaei","year":"2007","unstructured":"Kiaei M, Kipiani K, Calingasan NY, Wille E, Chen J, Heissig B et al (2007) Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol 205:74\u201381","journal-title":"Exp Neurol"},{"key":"1205_CR33","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1523\/JNEUROSCI.23-25-08733.2003","volume":"23","author":"GW Kim","year":"2003","unstructured":"Kim GW, Gasche Y, Grzeschik S, Copin JC, Maier CM, Chan PH (2003) Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption? J Neurosci 23:8733\u20138742","journal-title":"J Neurosci"},{"key":"1205_CR34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.critrevonc.2003.09.008","volume":"49","author":"E Lambert","year":"2004","unstructured":"Lambert E, Dass\u00e9 E, Haye B, Petitfr\u00e8re E (2004) TIMPs as multifacial proteins. Crit Rev Oncol Hematol 49:187\u2013198","journal-title":"Crit Rev Oncol Hematol"},{"key":"1205_CR35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1471-4159.1996.67010251.x","volume":"67","author":"GP Lim","year":"1996","unstructured":"Lim GP, Backstrom JR, Cullen MJ, Miller CA, Atkinson RD, T\u00f6k\u00e9s ZA (1996) Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J Neurochem 67:251\u2013259","journal-title":"J Neurochem"},{"key":"1205_CR36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-510X(02)00398-2","volume":"207","author":"S Lorenzl","year":"2003","unstructured":"Lorenzl S, Albers DS, LeWitt PA, Chirichigno JW, Hilgenberg SL, Cudkowicz ME et al (2003a) Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. J Neurol Sci 207:71\u201376","journal-title":"J Neurol Sci"},{"key":"1205_CR37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0197-0186(03)00004-4","volume":"43","author":"S Lorenzl","year":"2003","unstructured":"Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J et al (2003b) Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer\u2019s disease. Neurochem Int 43:191\u2013196","journal-title":"Neurochem Int"},{"key":"1205_CR38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.expneurol.2006.05.013","volume":"201","author":"AC Ludolph","year":"2006","unstructured":"Ludolph AC (2006) Matrix metalloproteinases: a conceptional alternative for disease-modifying strategies in ALS\/MND? Exp Neurol 201:277\u2013280","journal-title":"Exp Neurol"},{"key":"1205_CR39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2741\/1809","volume":"11","author":"A Mancini","year":"2006","unstructured":"Mancini A, Di Battista JA (2006) Transcriptional regulation of matrix metalloprotease gene expression in health and disease. Front Biosci 11:423\u2013446","journal-title":"Front Biosci"},{"key":"1205_CR40","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/01.STR.0000098648.54429.1C","volume":"34","author":"J Montaner","year":"2003","unstructured":"Montaner J, Fern\u00e1ndez-Cadenas I, Molina CA, Monasterio J, Arenillas JF, Rib\u00f3 M et al (2003) Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene. Stroke 34:2851\u20132855","journal-title":"Stroke"},{"key":"1205_CR41","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ceb.2009.06.006","volume":"21","author":"CJ Morrison","year":"2009","unstructured":"Morrison CJ, Butler GS, Rodr\u00edguez D, Overall CM (2009) Matrix metalloproteinase proteomics: substrates, targets, and therapy. Curr Opin Cell Biol 21:645\u2013653","journal-title":"Curr Opin Cell Biol"},{"key":"1205_CR42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3233\/JAD-130647","volume":"37","author":"B Mroczko","year":"2013","unstructured":"Mroczko B, Groblewska M, Barcikowska M (2013) The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study. J Alzheimers Dis 37:273\u2013283","journal-title":"J Alzheimers Dis"},{"key":"1205_CR43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.mam.2008.05.002","volume":"29","author":"G Murphy","year":"2008","unstructured":"Murphy G, Nagase H (2008) Progress in matrix metalloproteinase research. Mol Aspects Med 29:290\u2013308","journal-title":"Mol Aspects Med"},{"key":"1205_CR44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","volume":"69","author":"H Nagase","year":"2006","unstructured":"Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562\u2013573","journal-title":"Cardiovasc Res"},{"key":"1205_CR45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainres.2009.09.018","volume":"1301","author":"C Nicaise","year":"2009","unstructured":"Nicaise C, Mitrecic D, Demetter P, De Decker R, Authelet M, Boom A et al (2009) Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res 1301:152\u2013162","journal-title":"Brain Res"},{"key":"1205_CR46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2009.02775.x","volume":"17","author":"I Niebroj-Dobosz","year":"2010","unstructured":"Niebroj-Dobosz I, Janik P, Soko\u0142owska B, Kwiecinski H (2010) Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Neurol 17:226\u2013231","journal-title":"Eur J Neurol"},{"key":"1205_CR47","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/glia.20478","volume":"55","author":"RK Nuttall","year":"2007","unstructured":"Nuttall RK, Silva C, Hader W, Bar-Or A, Patel KD, Edwards DR et al (2007) Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia. Glia 55:516\u2013526","journal-title":"Glia"},{"key":"1205_CR48","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/mds.25022","volume":"27","author":"S O\u2019Dowd","year":"2012","unstructured":"O\u2019Dowd S, Curtin D, Waite AJ, Roberts K, Pender N et al (2012) C9ORF72 expansion in amyotrophic lateral sclerosis\/frontotemporal dementia also causesparkinsonism. Mov Disord 27:1072\u20131074","journal-title":"Mov Disord"},{"key":"1205_CR49","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1189\/jlb.69.6.851","volume":"69","author":"G Opdenakker","year":"2001","unstructured":"Opdenakker G, Van Den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S et al (2001) Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 69:851\u2013859","journal-title":"J Leukoc Biol"},{"key":"1205_CR50","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/wsbm.7","volume":"1","author":"A Pozzi","year":"2009","unstructured":"Pozzi A, Zent R (2009) Regulation of endothelial cell functions by basement membrane- and arachidonic acid-derived products. Wiley Interdiscip Rev Syst Biol Med 1:254\u2013272","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"1205_CR51","author":"F Puentes","year":"2013","unstructured":"Puentes F, Topping J, Kuhle J, van der Star BJ, Douiri A, Giovannoni G et al (2013) Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. doi: 10.1136\/jnnp-2013-305494","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1205_CR52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11912-004-0020-7","volume":"6","author":"N Ramnath","year":"2004","unstructured":"Ramnath N, Creaven PJ (2004) Matrix metalloproteinase inhibitors. Curr Oncol Rep 6:96\u2013102","journal-title":"Curr Oncol Rep"},{"key":"1205_CR53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000334862","volume":"67","author":"F Romi","year":"2012","unstructured":"Romi F, Helgeland G, Gilhus NE (2012) Serum levels of matrix metalloproteinases: implications in clinical neurology. Eur Neurol 67:121\u2013128","journal-title":"Eur Neurol"},{"key":"1205_CR54","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/364362c0","volume":"364","author":"DR Rosen","year":"1993","unstructured":"Rosen DR (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364:362","journal-title":"Nature"},{"key":"1205_CR55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1474-4422(09)70016-X","volume":"8","author":"GA Rosenberg","year":"2009","unstructured":"Rosenberg GA (2009) Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 8:205\u2013216","journal-title":"Lancet Neurol"},{"key":"1205_CR56","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1093\/hmg\/ddr227","volume":"20","author":"OA Ross","year":"2011","unstructured":"Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM et al (2011) Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet 20:3207\u20133212","journal-title":"Hum Mol Genet"},{"key":"1205_CR57","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.21543","volume":"65","author":"JD Rothstein","year":"2009","unstructured":"Rothstein JD (2009) Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65:S3\u2013S9","journal-title":"Ann Neurol"},{"key":"1205_CR58","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","volume":"344","author":"LP Rowland","year":"2001","unstructured":"Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344:1688\u20131700","journal-title":"N Engl J Med"},{"key":"1205_CR59","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1097\/00001756-199909090-00018","volume":"10","author":"BG Schoser","year":"1999","unstructured":"Schoser BG, Blottner D (1999) Matrix metalloproteinases MMP-2, MMP-7 and MMP-9 in denervated human muscle. NeuroReport 10:2795\u20132797","journal-title":"NeuroReport"},{"key":"1205_CR60","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000086679","volume":"25","author":"JJ Sejvar","year":"2005","unstructured":"Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB (2005) Amyotrophic lateral sclerosis mortality in the United States, 1979\u20132001. Neuroepidemiology 25:144\u2013152","journal-title":"Neuroepidemiology"},{"key":"1205_CR61","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jnnp.2006.103564","volume":"78","author":"CL Shoesmith","year":"2007","unstructured":"Shoesmith CL, Findlater K, Rowe A, Strong MJ (2007) Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry 78:629\u2013631","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1205_CR62","first-page":"117","volume":"60","author":"B Sokolowska","year":"2009","unstructured":"Sokolowska B, Jozwik A, Niebroj-Dobosz I, Janik P, Kwiecinski H (2009) Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods. J Physiol Pharmacol 60:117\u2013120","journal-title":"J Physiol Pharmacol"},{"key":"1205_CR63","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.nmd.2009.11.015","volume":"20","author":"CP Soon","year":"2010","unstructured":"Soon CP, Crouch PJ, Turner BJ, McLean CA, Laughton KM, Atkin JD et al (2010) Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice. Neuromuscul Disord 20:260\u2013266","journal-title":"Neuromuscul Disord"},{"key":"1205_CR64","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","volume":"17","author":"MD Sternlicht","year":"2001","unstructured":"Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463\u2013516","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1205_CR65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/alzrt44","volume":"2","author":"E Stomrud","year":"2010","unstructured":"Stomrud E, Bj\u00f6rkqvist M, Janciauskiene S, Minthon L, Hansson O (2010) Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer\u2019s disease. Alzheimers Res Ther 2:20","journal-title":"Alzheimers Res Ther"},{"key":"1205_CR66","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/14660820410021267","volume":"6","author":"MJ Strong","year":"2005","unstructured":"Strong MJ, Gordon PH (2005) Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum? Amyotroph Lateral Scler Other Motor Neuron Disord 6:8\u201316","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"1205_CR67","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/WNL.0b013e3181d5dc3b","volume":"74","author":"SD S\u00fcssmuth","year":"2010","unstructured":"S\u00fcssmuth SD, Sperfeld AD, Hinz A, Brettschneider J, Endruhn S, Ludolph AC et al (2010) CSF glial markers correlate with survival in amyotrophic lateral sclerosis. Neurology 74:982\u2013987","journal-title":"Neurology"},{"key":"1205_CR68","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0002-9440(10)64887-0","volume":"160","author":"G Taraboletti","year":"2002","unstructured":"Taraboletti G, D\u2019Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V (2002) Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160:673\u2013680","journal-title":"Am J Pathol"},{"key":"1205_CR69","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00702-012-0806-y","volume":"119","author":"J Tarasiuk","year":"2012","unstructured":"Tarasiuk J, Ku\u0142akowska A, Drozdowski W, Kornhuber J, Lewczuk P (2012) CSF markers in amyotrophic lateral sclerosis. J Neural Transm 119:747\u2013757","journal-title":"J Neural Transm"},{"key":"1205_CR70","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1468-1331.2012.03777.x","volume":"19","author":"R Tortelli","year":"2012","unstructured":"Tortelli R, Ruggieri M, Cortese R, D\u2019Errico E, Capozzo R, Leo A et al (2012) Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression. Eur J Neurol 19:1561\u20131567","journal-title":"Eur J Neurol"},{"key":"1205_CR71","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/01.wnl.0000296811.19811.db","volume":"70","author":"PN Valdmanis","year":"2008","unstructured":"Valdmanis PN, Rouleau GA (2008) Genetics of familial amyotrophic lateral sclerosis. Neurology 70:144\u2013152","journal-title":"Neurology"},{"key":"1205_CR72","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/brain\/awg117","volume":"126","author":"RM Berg-Vos van den","year":"2003","unstructured":"van den Berg-Vos RM, Visser J, Franssen H, de Visser M, de Jong JM, Kalmijn S et al (2003) Sporadic lower motor neuron disease with adult onset: classification of subtypes. Brain 126:1036\u20131047","journal-title":"Brain"},{"key":"1205_CR73","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ana.22611","volume":"70","author":"MA Es van","year":"2011","unstructured":"van Es MA, Schelhaas HJ, van Vught PW, Ticozzi N, Andersen PM et al (2011) Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol 70:964\u2013973","journal-title":"Ann Neurol"},{"key":"1205_CR74","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jcp.21208","volume":"213","author":"MP Vincenti","year":"2007","unstructured":"Vincenti MP, Brinckerhoff CE (2007) Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you? J Cell Physiol 213:355\u2013364","journal-title":"J Cell Physiol"},{"key":"1205_CR75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-4-3","volume":"4","author":"LC Wijesekera","year":"2009","unstructured":"Wijesekera LC, Leigh PN (2009) Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4:3","journal-title":"Orphanet J Rare Dis"},{"key":"1205_CR76","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1474-4422(05)70042-9","volume":"4","author":"JM Winhammar","year":"2005","unstructured":"Winhammar JM, Rowe DB, Henderson RD, Kiernan MC (2005) Assessment of disease progression in motor neuron disease. Lancet Neurol 4:229\u2013238","journal-title":"Lancet Neurol"},{"key":"1205_CR77","first-page":"629","volume":"35","author":"RO Winter","year":"2003","unstructured":"Winter RO, Birnberg BA (2003) Tuesdays with Morrie versus Stephen Hawking: living or dying with ALS. Fam Med 35:629\u2013631","journal-title":"Fam Med"},{"key":"1205_CR78","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1471-4159.2008.05430.x","volume":"106","author":"MS Woo","year":"2008","unstructured":"Woo MS, Park JS, Choi IY, Kim WK, Kim HS (2008) Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia. J Neurochem 106:770\u2013780","journal-title":"J Neurochem"},{"key":"1205_CR79","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jcp.20948","volume":"211","author":"C Yan","year":"2007","unstructured":"Yan C, Boyd DD (2007) Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211:19\u201326","journal-title":"J Cell Physiol"},{"key":"1205_CR80","first-page":"121","volume":"43","author":"D Zawi\u015blak","year":"2009","unstructured":"Zawi\u015blak D, Borraty\u0144ska A, Tomik B, Pera J, Gryz-Kurek E, Szczudlik A (2009) The C(-1562)T polymorphism of the MMP-9 gene and the risk of sporadic amyotrophic lateral sclerosis. Neurol Neurochir Pol 43:121\u2013125","journal-title":"Neurol Neurochir Pol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1205-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-014-1205-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1205-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T10:51:49Z","timestamp":1689418309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-014-1205-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,22]]},"references-count":80,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1205"],"URL":"https:\/\/doi.org\/10.1007\/s00702-014-1205-3","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,22]]}}}